TryGOLD- Free

MIGRAINE DRUG MAY STOP SYMPTOMS BEFORE HEADACHE STARTS
THE WEEK India|October 06, 2024
TAKING THE MEDICATION ubrogepant at the first signs of a migraine attack can prevent debilitating headaches before they start and help people go about their daily lives with little or no symptoms, finds a new US study published in the journal Neurology.
MIGRAINE DRUG MAY STOP SYMPTOMS BEFORE HEADACHE STARTS

The study included 518 participants who experienced two to eight migraine attacks per month. All the participants experienced signs that a migraine was about to happen, such as sensitivity to light and sound, fatigue, neck pain or stiffness or dizziness. Participants were divided into two groups and asked to treat two migraine attacks during a two-month period.

This story is from the October 06, 2024 edition of THE WEEK India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MIGRAINE DRUG MAY STOP SYMPTOMS BEFORE HEADACHE STARTS
Gold Icon

This story is from the October 06, 2024 edition of THE WEEK India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM THE WEEK INDIAView All
TAKING WINGS AGAIN
THE WEEK India

TAKING WINGS AGAIN

Telangana plans to redevelop Warangal's Mamnoor airport, built by the Nizam and destroyed by the Indian Air Force during Hyderabad's annexation in 1948

time-read
8 mins  |
March 09, 2025
Identity tracking
THE WEEK India

Identity tracking

Without reading like a tutorial, The Tamils gives a comprehensive account of the community's history and culture

time-read
3 mins  |
March 09, 2025
THE ART OF WINNING
THE WEEK India

THE ART OF WINNING

The real drama of the Oscar race happens before the envelope opens

time-read
3 mins  |
March 09, 2025
Kala cotton is pure magic
THE WEEK India

Kala cotton is pure magic

One of the greatest things about being a fashion journalist in India is that you are never just one thing. Your stories can take you to glamorous fashion weeks across the world, and they can also take you to the remotest parts of India, allowing you to tell stories of people whose voices have been quietened. Like the farmers of the indigenous kala cotton plant.

time-read
2 mins  |
March 09, 2025
Revival mode
THE WEEK India

Revival mode

Jitendra Patwari has set off a generational shift in Madhya Pradesh Congress

time-read
3 mins  |
March 09, 2025
No freedom in appeasement
THE WEEK India

No freedom in appeasement

Fearsome gods and kings are appeased, not opposed. Through history, this ingrained placatory habit is ordained by all religions and cultures.

time-read
2 mins  |
March 09, 2025
NIA WILL TRY RANA FOR CHARGES THAT HAVE NOT BEEN DISCLOSED
THE WEEK India

NIA WILL TRY RANA FOR CHARGES THAT HAVE NOT BEEN DISCLOSED

A high-profile lawyer, Ujjwal Nikam has argued crucial cases for the government. He was special public prosecutor in the 1993 Mumbai bomb blasts case and the 26/11 attacks case. His arguments led to the conviction of terrorist Ajmal Kasab, who was executed in 2012.

time-read
3 mins  |
March 09, 2025
Men, too, have glass ceilings
THE WEEK India

Men, too, have glass ceilings

The more I read about rape, suicide, family troubles, unemployment, toxic masculinity, excessive religiosity and hysterical jingoism, the more I feel we have got hold of the wrong end of the stick.

time-read
2 mins  |
March 09, 2025
Jumbo love
THE WEEK India

Jumbo love

Laxmi, once forced to beg on Mumbai streets, found home and freedom at the Wildlife SOS - Elephant Conservation and Care Centre in Mathura

time-read
3 mins  |
March 09, 2025
THE DEVIL AND THE DETAILS
THE WEEK India

THE DEVIL AND THE DETAILS

The extradition of Tahawwur Rana, whom US President Donald Trump called a \"very violent man\", could tie loose ends related to 26/11 and lead to the uncovering of valuable intelligence on attacks planned on India thereafter

time-read
10+ mins  |
March 09, 2025

We use cookies to provide and improve our services. By using our site, you consent to cookies. Learn more